bpc 157 and tb 500 oral BPC-157 + TB-500 Research Compound Capsules BPC-157/TB-500 (10mg/20mg) for Research |

5-Amino-1MQ (10mg) 5-Amino-1MQ is a small-molecule NNMT inhibitor that works at the cellular level to influence NAD+ availability and methylation processes tied to fat metabolism

Sarnavazi, and L

CJC-1295/Ipamorelin delivers broader GH optimization for recovery, sleep, and anti-aging

CAS Number: 137525-51-0

Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)

You may also be at risk of experiencing side effects if you are living with preexisting medical conditions